Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity

Table 1 Demographic and clinical characteristics as well as laboratory results of the study subjects

	Controls (n = 51)	Patients (n = 51)	P value
Male, n (%)	28 (54.9)	32 (62.7)	0.42
Age (yr)	53.8 ± 13.9	55.2 ± 14.2	0.60
BMI (kg/m2)	26.0 ± 3.5	26.1 ± 4.4	0.95
Systolic blood pressure (mmHg)	128.3 ± 18.5	127.4 ± 27.1	0.84
Diastolic blood pressure (mmHg)	79.0 ± 10.0	76.0 ± 15.1	0.26
Heart rate (beats/min)	77.05 ± 49.82	76.74 ± 15.82	0.96
Fasting insulin (μU/mL)	10.6 (7.7-12.4)	13.3 (10.6-24.4)	< 0.001
HbA1c (%)	4.97 ± 0.50	4.03 ± 0.74	< 0.001
HOMA-IR	2.40 (1.59-3.08)	3.39 (2.74-5.50)	< 0.001
White blood cells (n/μL) × 103	7.4 ± 2.6	5.5 ± 4.6	0.13
Hemoglobin (g/dL)	14.8 ± 1.2	11.8 ± 2.1	< 0.001
Platelets (n/μL) × 103	225.766 ± 36.24	122.17 ± 94.23	< 0.001
Diabetes, n (%)	1 (2.0)	7 (13.7)	0.02
Use of diuretics, n (%)	0	14 (27.5)	< 0.001
Smoking status, n (%)			34.34
Current smokers	16 (31.4)	22 (43.1)
Non-smokers	26 (51.0)	23 (45.1)
Ex-smokers	9 (17.6)	5 (9.8)

Data presented as mean ± SD or as n (%) or as median value (interquartile range). BMI: Body mass index; HbA1c: Glycated hemoglobin 1c; HOMA-IR: Homeostasis model assessment equation.